Wednesday, September 28, 2022
HomeTop StoriesEli Lilly's new diabetes drug continues to point out promise as an...

Eli Lilly's new diabetes drug continues to point out promise as an weight problems therapy

Date:

Eli Lilly's new diabetes drug continues to point out promise as an weight problems therapy

Eli Lilly continues to work on commercializing its robust innovation pipeline, which is a key purpose the CNBC Investing Club owns the inventory.

- Advertisement -

Related stories

New Echos, Fire TVs and more expected

The robot elephant in the roomiRobot's Roomba. Source: iRobotOne question...

Latest stories

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

LEAVE A REPLY

Please enter your comment!
Please enter your name here